Chromium chloride administration causes a substantial reduction of coronary lipid deposits, aortic lipid deposits, and serum cholesterol concentration in rabbits

Biological Trace Element Research

Volumn 130, Issue 3, 2009, Pages 262-272

  Price Evans, David A ^a   Tariq, Mohammad ^a   Dafterdar, Rofaida ^a   Al Hussaini, Hussa ^a   Sobki, Samia H ^a  

^a Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Cardiac atherosclerosis; Hypercholesterolemic rabbit; Parenteral trivalent chromium

Indexed keywords

CHOLESTEROL; CHROMIUM CHLORIDE; LIPID; CHLORIDE; CHROMIUM; CHROMIUM DERIVATIVE; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; BLOOD CHEMISTRY; CHOLESTEROL BLOOD LEVEL; COMPUTER ANALYSIS; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG BLOOD LEVEL; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION TEST; LIPID STORAGE; LIVER FUNCTION TEST; MALE; NONHUMAN; NULL HYPOTHESIS; RABBIT; WEIGHT GAIN; ANIMAL; AORTA; BLOOD; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL CHEMISTRY; DIET; DISEASE MODEL; DRUG EFFECT; INFLAMMATION; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; LIPID METABOLISM; LIVER; METABOLISM; PATHOLOGY; RANDOMIZATION; TOXICITY TESTING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; AORTA; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHLORIDES; CHOLESTEROL; CHROMIUM; CHROMIUM COMPOUNDS; CLINICAL CHEMISTRY TESTS; CORONARY VESSELS; DIET; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; INFLAMMATION; INJECTIONS, INTRAMUSCULAR; KIDNEY; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; LIVER; MALE; RABBITS; RANDOM ALLOCATION; TOXICITY TESTS;

EID: 70349579149     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8333-x     Document Type: Article

References (30)

1. Vincent JB. Recent advances in the nutritional biochemistry of trivalent chromium. Proceedings of the Nutritional Society. 63, 41-47 (2004)
2. Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition. 16, 273-279 (1997)
3. Baruthio F Toxic effects of chromium and it's compounds Biologcal Trace Element Research. 32, 145-153 (1992)
4. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism. 41, 758-771 (1992)
5. Bahijiri SM, Mira SA, Mufti AM. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance test,serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Medical Journal. 21, 831-837 (2000)
6. Vinson JA, Mandarano MA, Shuta DL, Bagchi M, Bagchi D. Beneficial effects of novel IH636 Grape seed proanthocyanidin extract and niacin-bound chromium in a hamster atherosclerosis model. Molecular & Cellular Biochemistry. 240, 99-103 (2002) (Pubitemid 35385824)
7. Rabinovitz H, Friedsohn A, Leibovitz A, Gabay G, Rocas C, Habot B. The effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. International Journal for Vitamin and Nutritional Research. 74, 178-182 (2004)
8. Yang X, Li S-T, Dong F, Ren J, Sreejayan N. Insulin-sensitizing and cholesterol-lowering effects of chromium(D-phenylalaninine) Journal of Inorganic Biochemistry. 100, 1187-1193 (2006)
9. Atac IA, Peksel A, Yanardag B, Sonken BB, Doger MM, Bilen ZG. The effect of combined treatment with niacin and chromium (III) chloride on the different tissues of hyperlipemic rats. Drug and Chemical Toxicology. 29, 363-377 (2006)
10. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate. Diabetes Technology & Therapeutics. 8, 677-687 (2006)
11. Geohas J, Daly A, Juturu V, Finch M, Komorowski J. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: A placebo-controlled, double-blinded, randomized clinical trial. American Journal of Medical Sciences. 333, 145-153 (2007)
12. Kleefstra N, Houweling ST, Jansman FGA, Groenier KH, Gans ROB, Jong BM, Bakker SJL. Chromium treatment has no effect in patients with poorly controlled, insulin-treated Type 2 diabetes in an obese Western population, Diabetes Care. 29, 521-525 (2006)
13. Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S. Role of chromium supplementation in Indians with type 2 diabetes mellitus. The Journal of Nutritional Biochemistry. 13, 690-697 (2002)
14. Staub HW, Reussner G, Thiessen R. Serum cholesterol reduction by chromium in hypercholesterolemic rabbits. Science. 166, 746-747 (1969)
15. Schroeder HA, Balassa JJ. Influence of chromium, cadmium and lead on rat aortic lipids and circulating cholesterol. American Journal of Physiology. 209, 433-437 (1965)
16. Abraham AS, Brooks BA, Eylathu U. Chromium and cholesterol-induced atherosclerosis in rabbits. Annals of Nutrition and Metabolism. 35, 203-207 (1991)
17. Finking G, Hanke H. Nikolaj Nicolajewitsch Anitschow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis Research. 35, 1-7 (1997)
18. Shiomi M, Ito T, Tsukada T, Yata T, Ueda M. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ-an immunological study. Atherosclerosis and Thrombosis. 14, 931-937 (1994)
19. Shiomi M, Ito T, Shirashi M, Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHLrabbits. Risk factors related to coronary atherosclerosis are different to those related to aortic atherosclerosis. Atherosclerosis. 96, 43-52 (1992)
20. Ginsburg R, Davis K, Bristow MR, McKennett K, Kodsi SR, Billingham ME, Schroeder JS. Calcium antagonists suppress atherogenesis in aorta but not in intramural coronary arteries of cholesterol-fed rabbits. Laboratory Investigation. 49, 154-158 (1983)
21. Kitajima AS, Sakuma S, Uchinuno Y, Terano T, Miyazaki A, Hakamata H, Horiuchi S. Quantitative analyses of lesion areas of coronary atherosclerosis in cholesterol-fed rabbits. Journal of Veterinary Medical Science. 58, 855-860 (1996)
22. Tall AR, Yvan-Charvet L, Wang N. The failure of torcetrapib-was it the molecule or the mechanism? Atherosclerosis Thrombosis and Vascular Biology. 27, 257-260 (2007)
23. Pedersen TR, Thorgeirsson G, Troedsson L, Kristianson J, Berg K, Wilhelmsen L, Faergeman O, Strandberg TE, Cook TJ, Hagfelt T, Kjekhus J, Miettinen T, Olsson AG, Pyorala K, Wedel H on behalf of the Scandinavian Simvastatin Survival Study Group. Follow up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering. American Journal of Cardiology. 86, 257-262 (2000)
24. Ford I, Murray H, Packard CI, Shepherd J, Macfarlne PW, Cobbe SM. Long-term follow-up of the West of Scotland Coronary Prevention Study. New England Journal of Medicine. 357, 1477-1486 (2007)
25. Evans DAP, Tariq M, Morgan JS, Riley PJ, Sobki SH. A novel computer-based method for the measurement of the lipid "load" in the coronary vessels of rabbits. Journal of Pharmacological and Toxicological Methods. 56, 323-329 (2007)
26. Bleibel W, Kim S, D'Silva K, Lemmer ER. Drug-induced liver injury: Review article. Digestive Diseases and Sciences. 52, 2463-2471 (2007)
27. 3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. Journal of Biological Inorganic Chemistry. 10, 119-130 (2005)
28. Albarracin C, Fuqua B, Geohas J, Finch M, Komorowski JR, Effect of chromium picolinate and biotin combination on coronary risk lipids and lipoproteins in subjects with non-LDL-C(> = 130 mg/dl)in type 2 diabetes mellitus. Arteriosclerosis, Thrombosis and Vascular Biology. 25, p255. E98-E99. (2005)
29. Waldo SW, Li YF, Buono C, Zhao B, Billings EM, Chang J, Kruth HS. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. American Journal of Pathology. 172, 1112-1126 (2008)
30. Jenner A, Ren M, Rajendran R, Ning P, Huat TK, Watt K. Halliwell B. Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radical Biology and Medicine. 42, 559-566 (2007)